Newton One Investments LLC Has $309,000 Position in UnitedHealth Group Incorporated (NYSE:UNH)

Newton One Investments LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 9.3% in the 4th quarter, Holdings Channel reports. The fund owned 611 shares of the healthcare conglomerate’s stock after selling 63 shares during the quarter. Newton One Investments LLC’s holdings in UnitedHealth Group were worth $309,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the stock. Commonwealth Financial Services LLC increased its stake in UnitedHealth Group by 26.3% in the fourth quarter. Commonwealth Financial Services LLC now owns 1,004 shares of the healthcare conglomerate’s stock valued at $508,000 after acquiring an additional 209 shares during the period. Rockline Wealth Management LLC lifted its position in shares of UnitedHealth Group by 1.6% during the 4th quarter. Rockline Wealth Management LLC now owns 12,305 shares of the healthcare conglomerate’s stock worth $6,225,000 after buying an additional 192 shares during the period. Cullinan Associates Inc. raised its stake in UnitedHealth Group by 5.4% during the fourth quarter. Cullinan Associates Inc. now owns 18,498 shares of the healthcare conglomerate’s stock worth $9,357,000 after acquiring an additional 950 shares in the last quarter. Tempus Wealth Planning LLC grew its holdings in shares of UnitedHealth Group by 16.4% in the 4th quarter. Tempus Wealth Planning LLC now owns 1,003 shares of the healthcare conglomerate’s stock worth $507,000 after purchasing an additional 141 shares during the last quarter. Finally, Flavin Financial Services Inc. bought a new position in UnitedHealth Group during the 4th quarter valued at about $2,274,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 1.1 %

NYSE:UNH opened at $548.65 on Tuesday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a 50 day moving average price of $536.17 and a two-hundred day moving average price of $565.20. The company has a market cap of $504.91 billion, a P/E ratio of 35.40, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company posted $5.83 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analysts Set New Price Targets

A number of brokerages have weighed in on UNH. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Bank of America cut their target price on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Barclays dropped their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a report on Friday, January 10th. One research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.